Fellowship ​

Professor Hall was one of the first Australian health services researchers involved in the measurement of health-related quality of life.  Overall her publications demonstrate a major contribution across the field of health economics and health services research, with papers analyzing the relevance of research results for clinical and public health applications, an assessment of developing research methods and data infrastructure, and analysis of current policy issues.  She was Director of CHERE from its foundation in 1991 until 2012.  CHERE has collaborations with leading health economics scholars across the world and a strong history of attracting NHMRC and ARC research grants.

Elizabeth is an academic paediatrician with a national and international reputation for leadership in medical research, education and advocacy. Her focus is children with rare diseases (including Fetal Alcohol Spectrum Disorders), in immigration detention and developing settings, and Indigenous children. She founded and leads two national surveillance systems – the Australian Paediatric Surveillance Unit for rare childhood diseases and Paediatric Active Enhanced Disease Surveillance system, and has led the International Network of Paediatric Surveillance Units. She holds a prestigious NHMRC Practitioner Fellowship; is a Consultant for the Australian Human Rights Commission and the WHO; and is Member of the Order of Australia.

Vlado Perkovic is an international leader in kidney research, and Executive Director of the George Institute Australia. His research has demonstrated the benefits of several interventions in kidney disease, and seeks to prevent kidney failure through new treatments.  He has demonstrated that half or fewer people with kidney failure globally have access to dialysis, and established a prize to encourage development to address this gap. He writes guidelines in kidney and cardiovascular disease, is a board member of ACTA, a member of the NHMRC Health Translation Committee, and Chairs the International Society of Nephrology Association for Clinical Trials.

Professor Dore is a renowned infectious diseases physician and clinical epidemiologist. His characterisation of the hepatitis C virus (HCV) epidemic, has informed public health policy and positioned his group as an international leader in HCV epidemiology. His HCV therapeutic research among people who inject drugs has guided clinical management internationally and enhanced access to treatment for this marginalised population.  His high standing is evidenced by extensive conference invitations as well as an outstanding record of peer funding. This is matched by the respect he enjoys in the wider community. He would be a most influential addition to the Fellowship.

Simon Gandevia is a clinical neurophysiologist with a history of major discoveries about human movement control in health and disease.  His research covers three strands: (i) neural mechanisms of proprioception; (ii) neural control of muscle performance, especially during muscle fatigue; and (iii) control of human breathing muscles.  His work has provided insight into many disorders, including stroke, spinal cord injury, prior–‐polio, asthma, chronic obstructive pulmonary disease, and obstructive sleep apnoea.  Also, he was a founder of the Prince of Wales Medical Research Institute (now NeuRA) in 1992 and elected a Fellow of the Australian Academy of Science in 1998.